Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11081	Companies
243115	Keywords
171254	Articles
130874	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presents positive results from Phase 2-3 COVA study for severe Covid-19 at WCID Paris. Bio101 shows significant efficacy and safety in reducing risk of respiratory failure and death

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study Respiratory Failure
PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophytis a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
Biophytis présente les résultats de l'étude COVA de phase 2-3 sur le traitement du Covid-19 lors du WCID à Paris. Les résultats sont positifs avec réduction significative des risques

Biophytis COVID-19 COVA Résultats Phase 2-3
REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophy(s a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
Biophytis présente les résultats de l'étude COVA de phase 2-3 sur les formes sévères de Covid-19 lors du WCID à Paris. Des résultats positifs de réduction du risque de défaillance respiratoire et de mortalité sont révélés

Biophytis COVID-19 Résultats Positifs Étude COVA Réduction Du Risque De Mortalité
REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 2 years 2 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presented positive results of its Phase 2-3 COVA study for severe Covid-19 at WCID in Paris, showing reduction in respiratory failure and death rates

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study
BRIEF

published on 06/25/2024 at 23:05, 2 years 2 months ago

Biophytis Approves All Resolutions at General Meeting

Shareholders Biophytis General Meeting Resolutions
BRIEF

published on 06/25/2024 at 23:05, 2 years 2 months ago

Résultats de l'Assemblée Générale Mixte de Biophytis du 24 juin 2024

Biophytis Assemblée Générale Resolutions Quorum Vote
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 2 years 2 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation

Shareholders General Meeting Resolutions Approval Biophytis SA
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 2 years 2 months ago

RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024
Biophytis annonce l'approbation des résolutions lors de l'Assemblée Générale Mixte du 24 Juin 2024. Détails des décisions et perspectives de la société

Biophytis Biotechnologie Assemblée Générale Mixte Approbation Des Résolutions Développement De Traitements
BRIEF

published on 06/20/2024 at 07:05, 2 years 3 months ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine

Biophytis Partenariat Amérique Latine BIO101 Blanver
BRIEF

published on 06/20/2024 at 07:05, 2 years 3 months ago

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million

Biophytis Pharmaceuticals Latin America BIO101 Blanver

Accesswire

Published on 09/25/2026 at 00:30, 4 hours 17 minutes ago

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 4 hours 32 minutes ago

CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 6 hours 46 minutes ago

Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 17:45, 11 hours 2 minutes ago

Jo-Jo Announces Resignation of Director
Published on 09/24/2026 at 14:55, 13 hours 52 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 02:45, 2 hours 1 minute ago

Huagui Group: un acteur mondial sur deux marchés aquatiques de plus de 100 milliards de RMB, tandis que la racine de lotus de Honghu se classe au premier rang pour sa teneur en antioxydants
Published on 09/25/2026 at 02:45, 2 hours 1 minute ago

Huagui Group: A Global Player Across Two RMB100-Billion Aquatic Markets, as Honghu Lotus Root Ranks No. 1 in Antioxidant Content
Published on 09/24/2026 at 20:29, 8 hours 17 minutes ago

EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 9 hours 47 minutes ago

HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 10 hours 6 minutes ago

EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares

Les Echos

Published on 09/24/2026 at 18:31, 10 hours 15 minutes ago

LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:10, 10 hours 37 minutes ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 10 hours 47 minutes ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 10 hours 47 minutes ago

GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/24/2026 at 18:00, 10 hours 47 minutes ago

i2S : Résultats 1er semestre 2026

View all LES ECHOS COMFI WIRE